Be Aware of Changes in the Erythropoiesis-Stimulating Agent REMS Program

You'll hear about changes in the REMS requirements for prescribing erythropoiesis-stimulating agents (ESA) in cancer patients....

Exclusive Subscriber Content

  • Best in class medication learning
  • Concise recommendations
  • Hundreds of practical resources

Subscribe Now Learn More

Login to access this content.

Login